- Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946087/ )
- Teneligliptin in management of type 2 diabetes mellitus - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993264/ )
- Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778556/ )
- Teneligliptin: a review in type 2 diabetes - (https://pubmed.ncbi.nlm.nih.gov/26475720/ )
Teneligliptin (Zita Plus (20mg)) works by increasing the insulin released by the pancreas, and it helps in lowering the blood glucose level in the body.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Zita Plus (20mg) - Glenmark Pharmaceutical Ltd.
Zita Plus (20mg) Tablet
Generic : Teneligliptin
Substitute/Alternative Medication to Zita Plus (20mg)
When is Zita Plus (20mg) prescribed?
It is prescribed for -